TrialCancer chemotherapy and pharmacology2014

Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network.

Natalie Callander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.